These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 27371846

  • 1. [Lily polysaccharide 1 enhances the effect of metformin on proliferation and apoptosis of human breast carcinoma cells].
    Hou J, Li F, Li X, Mei Q, Mi M.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):780-3. PubMed ID: 27371846
    [Abstract] [Full Text] [Related]

  • 2. Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells.
    Queiroz EA, Puukila S, Eichler R, Sampaio SC, Forsyth HL, Lees SJ, Barbosa AM, Dekker RF, Fortes ZB, Khaper N.
    PLoS One; 2014 Jun; 9(5):e98207. PubMed ID: 24858012
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling.
    Malki A, Youssef A.
    Oncol Res; 2011 Jun; 19(6):275-85. PubMed ID: 21776823
    [Abstract] [Full Text] [Related]

  • 6. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis.
    Xue J, Zhang H, Liu W, Liu M, Shi M, Wen Z, Li C.
    Reproduction; 2013 Oct; 146(4):397-406. PubMed ID: 23904524
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H, Scholz C, Zang C, Schefe JH, Habbel P, Regierer AC, Schulz CO, Possinger K, Eucker J.
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [Abstract] [Full Text] [Related]

  • 9. The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.
    Li B, Takeda T, Tsuiji K, Kondo A, Kitamura M, Wong TF, Yaegashi N.
    Gynecol Endocrinol; 2013 Jan; 29(1):87-90. PubMed ID: 22835064
    [Abstract] [Full Text] [Related]

  • 10. Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro.
    Xin M, Wang Y, Ren Q, Guo Y.
    Biomed Pharmacother; 2019 Jan; 109():2084-2089. PubMed ID: 30551465
    [Abstract] [Full Text] [Related]

  • 11. Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.
    Silvestri A, Palumbo F, Rasi I, Posca D, Pavlidou T, Paoluzi S, Castagnoli L, Cesareni G.
    PLoS One; 2015 Jan; 10(8):e0136250. PubMed ID: 26291325
    [Abstract] [Full Text] [Related]

  • 12. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
    Scherbakov AM, Sorokin DV, Tatarskiy VV, Prokhorov NS, Semina SE, Berstein LM, Krasil'nikov MA.
    IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
    [Abstract] [Full Text] [Related]

  • 13. Effect of metformin on cell proliferation, apoptosis, migration and invasion in A172 glioma cells and its mechanisms.
    Xiong ZS, Gong SF, Si W, Jiang T, Li QL, Wang TJ, Wang WJ, Wu RY, Jiang K.
    Mol Med Rep; 2019 Aug; 20(2):887-894. PubMed ID: 31173255
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metformin promotes apoptosis in primary breast cancer cells by downregulation of cyclin D1 and upregulation of P53 through an AMPK-alpha independent mechanism.
    Yenmiş G, Beşli N, Yaprak Saraç E, Hocaoğlu Emre FS, Şenol K, Kanıgür G.
    Turk J Med Sci; 2021 Apr 30; 51(2):826-834. PubMed ID: 33350292
    [Abstract] [Full Text] [Related]

  • 16. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Rocha GZ, Dias MM, Ropelle ER, Osório-Costa F, Rossato FA, Vercesi AE, Saad MJ, Carvalheira JB.
    Clin Cancer Res; 2011 Jun 15; 17(12):3993-4005. PubMed ID: 21543517
    [Abstract] [Full Text] [Related]

  • 17. Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase.
    Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S.
    Horm Metab Res; 2013 May 15; 45(5):387-90. PubMed ID: 23225247
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative and pro-apoptotic effects of three fungal exocellular β-glucans in MCF-7 breast cancer cells is mediated by oxidative stress, AMP-activated protein kinase (AMPK) and the Forkhead transcription factor, FOXO3a.
    Queiroz EA, Fortes ZB, da Cunha MA, Barbosa AM, Khaper N, Dekker RF.
    Int J Biochem Cell Biol; 2015 Oct 15; 67():14-24. PubMed ID: 26255117
    [Abstract] [Full Text] [Related]

  • 19. Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells.
    Lu R, Yang J, Wei R, Ke J, Tian Q, Yu F, Liu J, Zhang J, Hong T.
    PLoS One; 2018 Oct 15; 13(6):e0198938. PubMed ID: 29897998
    [Abstract] [Full Text] [Related]

  • 20. Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo.
    Niu X, Li S, Wei F, Huang J, Wu G, Xu L, Xu D, Wang S.
    Breast Cancer; 2014 Mar 15; 21(2):223-30. PubMed ID: 22711315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.